MDS Nordion gets set to build Canadian cyclotron
In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the
In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the company’s capacity to produce iodine-123 and palladium-103. MDS Nordion currently operates two cyclotrons at the TRIUMF site located on the University of British Columbia campus and a third in Fleurus, Belgium. These facilities supply more than two-thirds of the world’s reactor-produced isotopes.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
